L3VLUP
ProSign in

EYE in the 13F filings

National Vision HLDGS Inc · CUSIP 63845R107

Sector · Medical devices and instrumentsTheme · Healthcare: biopharma and medtech· L3VLUP-defined
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
31 Mar 2024
the date the book describes
Filed
15 May 2024
latest of these filings; the earliest 9 May 2024
Managers listing it
7
at least, of 95 tracked, among listed positions
Comparable managers
93
filed both Q4 2023 and Q1 2024; 3 listed it in both
Shares listed
3,385,701
combined, among listed positions
Reported value
$75m
combined, at the quarter end

Among the 93 comparable managers: 6 buyers (opened or added shares) and 1 seller (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing EYE in Q1 2024

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q4 2023, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

7 of 7 holders

ActionFiling
Arrowstreet Capital LP1,740,806$39munder 0.1%Trimmed-150,34115 May 2024 (the filing on sec.gov)
Marshall Wace LLP949,254$21munder 0.1%Addedn.a.15 May 2024 (the filing on sec.gov)
Hudson Bay Capital Management LP270,943$6.0munder 0.1%Added+75,23215 May 2024 (the filing on sec.gov)
First Eagle Investment Management LLC207,352$4.6munder 0.1%Newnew9 May 2024 (the filing on sec.gov)
Maverick Capital Ltd117,484$2.6munder 0.1%Newnew15 May 2024 (the filing on sec.gov)
Winton Group Ltd61,854$1.4m0.10%Addedn.a.14 May 2024 (the filing on sec.gov)
PDT Partners LLC38,008$842k0.08%Added+6415 May 2024 (the filing on sec.gov)

Largest increases and reductions, by shares

Q4 2023 to Q1 2024, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (2)

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
5 in Q3 2024 to 5 in Q2 2026

Tracked managers listing it, at least.

035810201820192020202120222023202420252026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
EYE by quarter
QuarterHoldersReported valueBuyersSellers
Q4 20173$51mn.a.n.a.
Q1 20184$59mn.a.n.a.
Q2 20183$51mn.a.n.a.
Q3 20184$514mn.a.n.a.
Q4 20184$418mn.a.n.a.
Q1 20198$178mn.a.n.a.
Q2 20199$460mn.a.n.a.
Q3 20195$99mn.a.n.a.
Q4 20193$187mn.a.n.a.
Q1 20204$139mn.a.n.a.
Q2 20207$297mn.a.n.a.
Q3 20206$358mn.a.n.a.
Q4 20204$378mn.a.n.a.
Q1 20215$381mn.a.n.a.
Q2 20215$517mn.a.n.a.
Q3 20215$575mn.a.n.a.
Q4 20215$523mn.a.n.a.
Q1 20226$632mn.a.n.a.
Q2 20224$290mn.a.n.a.
Q3 20224$333mn.a.n.a.
Q4 20225$380mn.a.n.a.
Q1 20234$25mn.a.n.a.
Q2 20234$84mn.a.n.a.
Q3 20235$59mn.a.n.a.
Q4 20234$55m23
Q1 20247$75m61
Q2 20244$38m41
Q3 20245$44m50
Q4 20243$9.2m30
Q1 20256$79m42
Q2 20258$161m63
Q3 20257$300m61
Q4 20256$280m1018
Q1 20266$263m1512
Q2 20265$224m1513

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

EYE and LLY →EYE and JNJ →EYE and VRTX →Choose a stock to compare with EYE →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own EYE, latest filings →Back to the 13F Explorer →